QFQisang Fan

Qisang Fan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qisang Fan has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Bingyu Yang

    Department of Endocrinology, Genetics and Metabolism, Children’s Hospital of Soochow University , Suzhou 215003

    1 shared publication
  • Dandan Zhang

    Department of Endocrinology, Genetics and Metabolism, Children’s Hospital of Soochow University , Suzhou 215003

    1 shared publication
  • Haitao Lv

    Suzhou Clinical Center for Rare Diseases in Children, Children's Hospital of Soochow University, Suzhou, Jiangsu, China

    1 shared publication
  • Hongying Wang

    Suzhou Clinical Center for Rare Diseases in Children, Children’s Hospital of Soochow University , Suzhou 215003

    1 shared publication
  • Qing Wang

    Suzhou Clinical Center for Rare Diseases in Children, Children's Hospital of Soochow University, Suzhou, Jiangsu, China

    1 shared publication
  • Shengnan Wu

    Shanghai Children’s Hospital, Shanghai Jiao Tong University, Shanghai, Shanghai, China

    1 shared publication

Latest Publications

  • UBTFhaploinsufficiency associated withUBTF-related global developmental delay and distinctive facial features without neuroregression

    by Xueqian Wang, Bingyu Yang, Shengnan Wu, Qisang Fan, Qing Wang, Dandan Zhang, Hongying Wang, Tao Feng, Haitao Lv, Ting Chen

    Background: The Upstream Binding Transcription Factor (UBTF) gene encodes two nucleolar proteins, UBTF1 and UBTF2. UBTF1 regulates rRNA transcription by RNA polymerase I, while UBTF2 regulates mRNA transcription by RNA polymerase II. A recurrent de novo dominant mutation c.628G>A (p.Glu210Lys) has been identified as a gain-of-function mutation associated with childhood onset neurodegeneration with brain atrophy (CONDBA). Evidence from large-scale population databases andUbtf+/−mouse models indicates thatUBTFhaploinsufficiency is not tolerated.Methods: Three unrelated patients with global developmental delay and distinctive facial features were recruited for the study. Whole exome sequencing (WES) was performed to identify potential genetic abnormalities. Additionally, copy number variation analysis was conducted based on the WES data.Results: All three patients exhibited intellectual disabilities, social challenges and developmental delays in language and gross motor skills. Distinctive facial features included a wide forehead, sparse eyebrows, hypertelorism, narrow palpebral fissures, single-fold eyelids, a flat nasal bridge, anteverted nares, a long philtrum and a thin upper lip. Additionally, patient C presented with more severe language delay, recurrent hepatic dysfunction and an atrial septal defect. Patient A was found to have a nonsense variant, c.1327C>T (p.R443Ter), in the exon 13 ofUBTF. Patients B and C both carried a heterozygous deletion encompassing theUBTFgene.Conclusion: In this study, we analysed the detailed phenotypes associated withUBTFhaploinsufficiency, which, to our knowledge, have not been previously reported. We propose thatUBTFhaploinsufficiency-related global developmental delay and distinctive facial features, without neuroregression, constitute a new syndrome distinct from CONDBA.